Hypertension treatment practices and its determinants among ambulatory patients:Retrospective cohort study in Ethiopia

Objectives We examined determinants of achieving blood pressure control in patients with hypertension and of treatment intensification in patients with uncontrolled blood pressure (BP).Design A retrospective cohort study in six public hospitals, Ethiopia.Participants Adult ambulatory patients with hypertension and with at least one previously prescribed antihypertensive medication in the study hospital.Outcome Controlled BP (&lt;140/90 mm Hg) and treatment intensification of patients with uncontrolled BP.Results The study population comprised 897 patients. Their mean age was 57 (SD 14) years, 63% were females, and 35% had one or more cardiometabolic comorbidities mainly diabetes mellitus. BP was controlled in 37% of patients. Treatment was intensified for 23% patients with uncontrolled BP. In multivariable (logistic regression) analysis, determinants positively associated with controlled BP were treatment at general hospitals (OR 1.89, 95% CI 1.26 to 2.83) compared with specialised hospitals and longer treatment duration (OR 1.04, 95% CI 1.01 to 1.06). Negatively associated determinants were previously uncontrolled BP (OR 0.30, 95% CI 0.21 to 0.43), treatment regimens with diuretics (OR 0.68, 95% CI 0.50 to 0.94) and age (OR 0.99, 95% CI 0.98 to 1.00). The only significant-positive-determinant for treatment intensification was duration of therapy (OR 1.05, 95% CI 1.02 to 1.09).Conclusions The level of controlled BP and treatment intensification practice in this study was low. The findings suggest the need for in-depth understanding and interventions of the identified determinants such as uncontrolled BP on consecutive visits, older age and type of hospital.</p

Impact of Treatment Satisfaction and Adverse Drug Events on Antihypertensive Medication Adherence in Ambulatory Patients in Ethiopia

To explore the impact of treatment satisfaction and self-claimed adverse drug events (ADEs) on antihypertensive medication adherence in Ethiopian ambulatory patients

Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015

<div><p>The prevalence of diabetes, dyslipidemias, and high blood pressure is increasing worldwide especially in low and middle income countries. World Health Organization has emphasized the importance of the assessment of the magnitude of the specific disease in each country. We determined the prevalence and determinant factors of high blood pressure, hyperglycemia, dyslipidemias and metabolic syndrome in Ethiopia. A community based survey was conducted from -April to June 2015 using WHO NCD STEPS instrument version 3.1. 2008. Multistage stratified systemic random sampling was used to select representative samples from 9 regions of the country. A total of 10,260 people aged 15–69 years participated in the study. Blood pressure (BP) was measured for 9788 individuals. A total of 9141 people underwent metabolic screening. The prevalence of raised blood pressure (SBP ≥140 and/or DBP ≥ 90 mmHg) was 15.8% (16.3% in females and 15.5% in males). The prevalence of diabetes mellitus (FBS ≥ 126 mg /dl) including those on medication was 3.2% (3.5% males and 3.0% females). The prevalence of impaired fasting glucose was 9.1% with ADA criteria and 3.8% with WHO criteria. Hypercholesterolemia was found in 5.2%, hypertriglyceridemia in 21.0%, high LDL cholesterol occurred in 14.1% and low HDL cholesterol occurred in 68.7%. The prevalence of metabolic syndrome using IDF definition was 4.8% (8.6% in females and vs. 1.8% in males). Advanced age, urban residence, lack of physical exercise, raised waist circumference, raised waist hip ratio, overweight or obesity, and total blood cholesterol were significantly associated with raised blood pressure (BP) and diabetes mellitus. Increased waist- hip ratio was an independent predictor of raised blood pressure, hyperglycemia and raised total cholesterol. Our study showed significantly high prevalence of raised blood pressure, hyperglycemia and dyslipidemia in Ethiopia. Community based interventions are recommended to control these risk factors.</p></div

Bivariate and multivariate analyses of demographic and clinical risk factors for raised blood pressure, raised blood sugar, raised total cholesterol level, Ethiopia NCD Steps 2015.

<p>Bivariate and multivariate analyses of demographic and clinical risk factors for raised blood pressure, raised blood sugar, raised total cholesterol level, Ethiopia NCD Steps 2015.</p

Prevalence of raised total cholesterol level and metabolic syndrome, and their determinants WHO STEPS survey, Ethiopia 2015.

<p>Prevalence of raised total cholesterol level and metabolic syndrome, and their determinants WHO STEPS survey, Ethiopia 2015.</p

Prevalence of dyslipidemia, WHO STEPS survey, Ethiopia 2015.

<p>Prevalence of dyslipidemia, WHO STEPS survey, Ethiopia 2015.</p

Prevalence of raised blood pressure, hyperglycemia and their determinants, WHO STEPs study, 2015, Ethiopia.

<p>Prevalence of raised blood pressure, hyperglycemia and their determinants, WHO STEPs study, 2015, Ethiopia.</p

Mean and SD values of total cholesterol, blood glucose, diastolic and systolic blood pressure, Ethiopia NCD steps, 2015.

<p>Mean and SD values of total cholesterol, blood glucose, diastolic and systolic blood pressure, Ethiopia NCD steps, 2015.</p